NIB Holdings Ltd (ASX: NHF) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

NIB Holdings Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $2.81 billion
P/E Ratio 15.73
Dividend Yield 4.89%
Shares Outstanding 485.08 million
Earnings per share 0.377
Dividend per share 0.28
Year To Date Return -19.89%
Earnings Yield 6.36%
Franking 100%
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • NIB Holdings Ltd (ASX: NHF)
    Latest News

    a woman
    Share Market News

    5 things to watch on the ASX 200 on Thursday

    Fortescue Metals Group Limited (ASX:FMG), Ramsay Health Care Limited (ASX: RHC), and Rio Tinto Limited (ASX:RIO) shares will be on…

    Read more »

    a woman
    ⏸️ Dividend Shares

    Telstra and 6 other blue chip shares trade ex-dividend next week

    Telstra Corporation Ltd (ASX:TLS) shares and six other blue chips will trade ex-dividend next week. Here's when you need to…

    Read more »

    a woman
    Share Market News

    Leading brokers name 3 ASX shares to sell today

    Bank of Queensland Limited (ASX:BOQ) shares are one of three that leading brokers have rated as sells this week...

    Read more »

    a woman
    Share Gainers

    NIB share price climbs higher on solid first half result and guidance upgrade

    The NIB Holdings Limited (ASX:NHF) share price has pushed higher following the release of a strong first half result. Should…

    Read more »

    a woman
    Share Market News

    5 things to watch on the ASX 200 on Monday

    Altium Limited (ASX:ALU), NIB Holdings Limited (ASX:NHF), and Oil Search Limited (ASX:OSH) shares will be on watch on Monday. Here's…

    Read more »

    a woman
    52-Week Highs

    UBS says take profit on this market darling as its share price hits a record high

    The Idp Education Ltd (ASX: IEL) share price hit a record high during lunch time trade but this could be…

    Read more »

    a woman
    Share Fallers

    Should you buy Bellamy's Australia and 2 other beaten down ASX shares?

    The Bellamy's Australia Ltd (ASX:BAL) share price is one of three that have fallen heavily over the last 12 months.…

    Read more »

    a woman
    Healthcare Shares

    Is the Ramsay Health Care share price a buy?

    The Ramsay Health Care Limited (ASX: RHC) share price has just recovered from hitting its lowest level in four years…

    Read more »

    a woman
    Share Market News

    ALL ORDINARIES finishes lower Thursday: 10 shares you missed

    The S&P/ASX 200 (Index:^AXJO)(ASX:XJO) and ALL ORDINARIES (Index:^AXAO) (ASX:XAO) finished lower on Thursday.

    Read more »

    a woman
    Share Market News

    ALL ORDINARIES finishes lower Wednesday: 8 shares you missed

    The S&P/ASX 200 (Index:^AXJO)(ASX:XJO) and ALL ORDINARIES (Index:^AXAO) (ASX:XAO) finished lower on Wednesday.

    Read more »

    a woman
    Share Market News

    Wednesday's ASX 200 lunch time report

    Bega Cheese Ltd (ASX:BGA), Medibank Private Ltd (ASX:MPL), Woodside Petroleum Limited (ASX:WPL) shares have been making a splash on the…

    Read more »

    a woman
    Share Gainers

    Medibank Private and NIB Holdings shares higher on premium increase news

    The Medibank Private Ltd (ASX:MPL) share price and the NIB Holdings Limited (ASX:NHF) share price are both higher in morning…

    Read more »

    Frequently Asked Questions

    The company was established as Newcastle Industrial Benefits (NIB) Hospital Fund in 1952 to provide health insurance for workers at BHP Steelworks, Mayfield. It changed its name to NIB Health Funds Ltd in 1966.

    In 2007 members voted in favour of demutualising the health fund, and in November that year, NIB became the first Australian private health insurer to list on the ASX.

    NIB pays a fully franked dividend in April and October.

    Dividend Payment History Data provided by Morningstar.

    Data provided by Morningstar.
    Ex-Date Amount Franking Type Payable
    05 Sep 2024 $0.1400 100.00% Final 08 Oct 2024
    07 Mar 2024 $0.1500 100.00% Interim 10 Apr 2024
    04 Sep 2023 $0.1500 100.00% Final 03 Oct 2023
    02 Mar 2023 $0.1300 100.00% Interim 03 Apr 2023
    05 Sep 2022 $0.1100 100.00% Final 04 Oct 2022
    03 Mar 2022 $0.1100 100.00% Interim 04 Apr 2022
    02 Sep 2021 $0.1400 100.00% Final 05 Oct 2021
    04 Mar 2021 $0.1000 100.00% Interim 06 Apr 2021
    03 Sep 2020 $0.0400 100.00% Final 06 Oct 2020
    05 Mar 2020 $0.1000 100.00% Interim 07 Apr 2020
    02 Sep 2019 $0.1300 100.00% Final 30 Sep 2019
    06 Sep 2018 $0.1100 100.00% Final 05 Oct 2018
    01 Mar 2018 $0.0900 100.00% Interim 03 Apr 2018
    07 Sep 2017 $0.0000 100.00% Final 06 Oct 2017
    02 Mar 2017 $0.0850 100.00% Interim 03 Apr 2017
    08 Sep 2016 $0.0900 100.00% Final 07 Oct 2016
    02 Mar 2016 $0.0575 100.00% Interim 01 Apr 2016
    10 Sep 2014 $0.0900 100.00% Special Cash 03 Oct 2014
    10 Sep 2014 $0.0575 100.00% Final 03 Oct 2014
    05 Sep 2013 $0.0500 100.00% Final 04 Oct 2013
    04 Mar 2013 $0.0500 100.00% Interim 05 Apr 2013
    05 Mar 2012 $0.0425 100.00% Interim 05 Apr 2012
    07 Mar 2011 $0.0400 100.00% Interim 08 Apr 2011
    05 Mar 2010 $0.0200 100.00% Interim 08 Apr 2010
    14 Sep 2009 $0.0440 100.00% Final 09 Oct 2009

    NHF ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About NIB Holdings Ltd

    NIB Holdings Limited (ASX: NHF) provides health and medical insurance to more than 1.5 million Australian and New Zealand residents.

    In addition, it covers more than 180,000 international students and workers in Australia.

    The company also offers travel insurance through its NIB Travel business,  and provides health insurance plans to corporate groups through its GU Health business.

    NHF Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    15 Nov 2024 $5.79 $0.08 1.40% 810,713 $5.78 $5.81 $5.74
    14 Nov 2024 $5.71 $0.01 0.18% 1,045,229 $5.70 $5.76 $5.69
    13 Nov 2024 $5.70 $-0.26 -4.36% 1,639,921 $5.64 $5.80 $5.61
    12 Nov 2024 $5.96 $-0.04 -0.67% 2,397,746 $5.70 $6.04 $5.58
    11 Nov 2024 $6.00 $-0.08 -1.32% 658,341 $6.10 $6.14 $5.99
    08 Nov 2024 $6.08 $0.05 0.83% 606,436 $6.08 $6.14 $6.07
    07 Nov 2024 $6.03 $0.11 1.86% 1,221,464 $6.03 $6.09 $5.98
    06 Nov 2024 $5.92 $0.11 1.89% 575,617 $5.87 $5.95 $5.84
    05 Nov 2024 $5.81 $-0.02 -0.34% 741,190 $5.78 $5.83 $5.77
    04 Nov 2024 $5.83 $0.02 0.34% 855,508 $5.87 $5.87 $5.80
    01 Nov 2024 $5.81 $0.03 0.52% 864,072 $5.76 $5.84 $5.72
    31 Oct 2024 $5.78 $-0.04 -0.69% 1,730,091 $5.82 $5.86 $5.76
    30 Oct 2024 $5.82 $-0.06 -1.02% 1,009,458 $5.87 $5.89 $5.82
    29 Oct 2024 $5.88 $-0.03 -0.51% 920,034 $5.91 $5.95 $5.85
    28 Oct 2024 $5.91 $-0.05 -0.84% 924,201 $5.96 $5.96 $5.89
    25 Oct 2024 $5.96 $0.02 0.34% 676,858 $5.94 $6.02 $5.93
    24 Oct 2024 $5.94 $-0.01 -0.17% 1,290,407 $5.94 $5.98 $5.91
    23 Oct 2024 $5.95 $0.00 0.00% 913,796 $5.94 $5.97 $5.87
    22 Oct 2024 $5.95 $-0.08 -1.33% 1,174,198 $5.99 $6.00 $5.92
    21 Oct 2024 $6.03 $0.00 0.00% 1,004,507 $6.08 $6.08 $6.00
    18 Oct 2024 $6.03 $-0.06 -0.99% 1,428,190 $6.05 $6.09 $6.00
    17 Oct 2024 $6.09 $0.03 0.50% 1,255,947 $6.15 $6.15 $6.04
    16 Oct 2024 $6.06 $-0.10 -1.62% 1,091,444 $6.14 $6.14 $6.06

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    12 Sep 2024 Mark Fitzgibbon Sell 81,760 $477,719
    On-market trade.
    11 Sep 2024 Mark Fitzgibbon Sell 58,240 $334,921
    On-market trade.
    10 Sep 2024 Mark Fitzgibbon Sell 60,000 $346,435
    On-market trade.
    02 Sep 2024 Mark Fitzgibbon Exercise 301,979 $1,938,705
    Conversion of securities. 605,045 Rights
    02 Sep 2024 Mark Fitzgibbon Issued 301,979 $1,938,705
    Conversion of securities.
    02 Sep 2024 Mark Fitzgibbon Expiry 12,813 $82,259
    As advised by the company. Lapsed, 907,024 Rights
    02 Sep 2024 Mark Fitzgibbon Buy 85,685 $550,097
    On-market trade.
    27 Aug 2024 Jill Watts Buy 4,885 $29,945
    On-market trade.
    27 Aug 2024 Brad Welsh Buy 3,174 $19,044
    On-market trade.
    18 Apr 2024 Mark Fitzgibbon Transfer 20,000 $152,000
    Off-market transfer.
    18 Apr 2024 Mark Fitzgibbon Transfer 20,000 $152,000
    Off-market transfer.
    12 Mar 2024 Mark Fitzgibbon Sell 35,000 $277,018
    On-market trade.
    08 Dec 2023 Jill Watts Buy 3,154 $23,497
    On-market trade.
    01 Dec 2023 Mark Fitzgibbon Issued 195,046 $1,503,804
    Issue of securities. 9,19,837 Rights
    23 Nov 2023 Mark Fitzgibbon Transfer 22,000 $165,000
    Off-market transfer.
    23 Nov 2023 Mark Fitzgibbon Transfer 22,000 $165,000
    Off-market transfer.
    22 Nov 2023 Jill Watts Buy 162 $1,200
    On-market trade.
    20 Nov 2023 Jill Watts Buy 4,021 $29,996
    On-market trade.

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Mr David L Gordon Non-Executive DirectorNon-Executive Chairman May 2020
    Mr Gordon has over 30 years of of experience as a director of public and private companies and in corporate advisory roles to Australian and international organisations. He brings knowledge of strategy development, mergers and acquisitions, as well as capital raisings, IPOs and joint ventures. David also has a track record in guiding businesses to grow and harness their digital capability to explore and develop new products and markets. David has held a number of roles with Freehills (Partner) and boutique investment bank Wentworth Associates. In addition, he founded independent corporate advisory and investment firm, Lexicon Partners in 2001. David is currently Chair of Accent Group Limited. He is Chair of General Homecare Holdings Pty Ltd, Shippit Pty Ltd, Genesis Capital Manager I Pty Ltd and Genesis Capital Manager II Pty Ltd (the management entities of the Genesis Capital Fund I and Genesis Capital Fund II healthcare investment funds, respectively). He is also a Non-Executive Director of international not-for-profit organisation, High Resolves.
    Ms Anne Joan Loveridge Non-Executive Director Feb 2017
    Ms Loveridge has over 35 years of experience in the regulated financial services sector, including health insurance. She has knowledge of financial and regulatory reporting, risk management and compliance frameworks. She also has over eight years of experience as a Non-Executive Director for ASX-listed entities in the financial services sector. Formally trained as a Chartered Accountant, Anne has experience in financial reporting, auditing, risk, ethics and regulatory affairs following her 31 years with PwC in the UK and Australia, where she was a Senior Audit Partner and Deputy Chair of the Australian Firm until 2015. Anne is a Non-Executive Director of National Australia Bank Limited, Platinum Asset Management and Accent Group Limited. Anne is a Non-Executive Director of Destination NSW. Anne was appointed to the Board of nib holdings limited in February 2017. She is the Chair of the Audit Committee and a member of the Nomination Committee and the Risk and Reputation Committee. She is member of Risk and Reputation Committee.
    Mr Donal Paul O'Dwyer Non-Executive Director Mar 2016
    Mr O'Dwyer has knowledge of the health industry globally, after more than 35 years in senior executive and Non-Executive Director roles within the healthcare products and medical device sectors. Starting his career as a qualified civil engineer, he went on to gain experience in business, science, engineering, manufacturing and management. During his tenure with Baxter Healthcare, he rose through the ranks from plant manager to President of the Cardiovascular Group Europe, gaining understanding of the inner workings of business strategy and fiscal management, from the floor of the factory through to the boardroom. He then worked for Cordis (the cardiovascular device franchise of Johnson & Johnson) - initially as European President and later, when he located to the US, he served as Worldwide President. Donal has interest in environmental, social and governance factors and how these performance indicators can help promote long term financial success. Former directorships of listed entities in the past three year - Non-Executive Director of Fisher & Paykel Healthcare Corporation Ltd and Mesoblast Ltd. He is a member of the People Committee.
    Mark Fitzgibbon Chief Executive OfficerManaging Director May 2007
    Mr Fitzgibbon is a Director of nib health funds limited, as well as other nib holdings limited's subsidiaries. Mark has held executive positions at a number of Australian organisations, including local government councils and peak industry bodies. As Managing Director, Mark's focus has been to grow and diversify nib's business and with that, earnings by leveraging nib's capability, systems and people. This has seen nib grow in recent years organically and inorganically, in existing and new markets. Mark has previously served as CEO of the national and NSW peak industry bodies for licensed clubs, as well as holding several General Manager positions in local government.
    Mr Peter Harmer Non-Executive Director Jul 2021
    Mr Harmer has over 40 years of experience in the Australian and international insurance and financial sectors, including over 30 years in a senior executive capacity. He has understanding of the global insurance and reinsurance markets and has driven the improvement of business and customer experiences through digital innovation. During his career, Peter accelerated digital engagement through re-examining customer journeys to understand pain points and introduced the right tools and technology to help improve the overall customer experience. In addition, he has been focused on the development and design of working methodologies combined with Human Centred Design thinking to ensure practice in employee productivity, performance, health and wellbeing. Peter was formerly Chief Executive Officer of Insurance Australia Group (IAG), CGU Insurance, Aon Limited UK, Aon Risk Services Australia Pacific and Aon Re Australia and has led business' growth agendas, major acquisitions, and industry roll ups. Prior to his role as Chief Executive Officer at IAG, he took up a secondment role as Chief Digital Officer to help drive IAG's digital strategy. This included building a centralised capability to improve the customer experience through the utilisation of new technology and data insights. Peter is currently a Non-Executive Director of Commonwealth Bank of Australia, AUB Group Limited, and Tysers Insurance Broker Ltd, which is based in London, UK and is 100% owned by AUB Group Limited. Peter is the Chair of Lawcover Insurance Pty Ltd. He is also a member of the Advisory Council for Bain & Company, and Chair of the Asia/Pacific Advisory Council for EXL Services Limited. He is the Chair of the Risk and Reputation Committee and a member of the People Committee.
    Ms Jacqueline Chow Non-Executive Director Apr 2018
    Ms Chow has more than 20 years of experience working with global blue-chip consumer product multinationals in a range of executive and non-executive positions in general management, strategy, marketing as well as technology and innovation. Her early career concentrated on business analytics, brand equity and marketing. She has also led business transformation by driving productivity and efficiencies, as well as embedding leadership behaviours and change. Jacqueline contributes toward ensuring the sustainability of the organisations she serves in the areas of climate scenario impacts, human rights and supply chain resilience. Jacqueline has global experience driving strategic growth and innovation across customer and consumer brands for the likes of Fonterra, Campbell Arnott's and the Kellogg Company. She was previously Deputy Chair of Global Dairy Platform and a Director of Fisher & Paykel Appliances in New Zealand, Dairy Partners Americas, the Riddet Institute (Massey University NZ) and The Arnott's Foundation. Jacqueline is a senior advisor with McKinsey & Company's Transformation Practice where she advises clients across resources, retail, financial services, telecommunications and consumer sectors on organisational change and high performance culture. Jacqueline is currently a Non-Executive Director of Coles Group Limited and Charter Hall Group. Former directorships of listed entities in the past three years - Independent Non-Executive Director of Boral Limited. Jacqueline is a Non-Executive Director of the Australia-Israel Chamber of Commerce. She is Chair of the People Committee.
    Mr Brad Welsh Non-Executive Director Jul 2023
    Mr Welsh has spent more than a decade leading and advising global resource companies, including Energy Resources of Australia and Rio Tinto, bringing public sector and commercial skills to his role on nib's Board. Through his leadership roles in mining and energy, Brad has focused on operational efficiency, safety and building long-term relationships of trust with key stakeholders, including traditional landowners. Through media and senior advisory roles in the Office of the NSW Premier, the Minister for Planning, and the Prime Minister of Australia, he has acquired understanding of the public sector. Directorships of listed entities - Chief Executive Officer and Managing Director at Energy Resources of Australia Limited. Brad has been admitted as a solicitor to the NSW Supreme Court. He is a member of the Risk and Reputation Committee and People Committee.
    Ms Jill Watts Non-Executive Director Jul 2023
    Ms Watts has more than 40 years of experience leading global businesses. She has worked across the private sector, with governments affecting public policy change, and private research institutes. She has gained experience working with companies with operations in Australia, the UK, France, and South Africa. Prior to returning to Australia in 2017, Jill was the Group CEO of the UK's private hospital group, BMI Healthcare, responsible for 60 facilities across the UK. Jill was also Group CEO of Ramsay Healthcare, UK. In 2010, Jill was voted the most influential leader in UK Private Health Care. She has joined the Boards of a range of global companies since returning to Australia. Jill is currently a Non-Executive Director of IHH Healthcare Berhad, which is dual listed in Singapore and Malaysia. Jill is a prior Director of the Australian Chamber of Commerce, UK; The Royal Australian Flying Doctor Service, UK; Netcare Hospital Group, South Africa; Ramsay Generale de Sante, France; and Healthcare Logic Global Group. Jill is currently a Non-Executive Director at St Vincent's Healthcare and she is a Non-Executive Director at Icon Cancer Group. She is also a Board member at Keyton, a retirement villages business, formerly known as Lendlease Retirement Living. She is a member of the Risk and Reputation Committee.
    Ms Roslyn Toms Group Executive - Legal and Chief Risk OfficerCompany Secretary Apr 2013
    -
    Mr Jordan French Senior Corporate CounselJoint Company Secretary Aug 2017
    -
    Martin Adlington Chief Executive
    -
    Rob Hennin Chief Executive Officer nib New Zealand & nib Travel
    -
    Edward Close Chief Executive Australian Residents Health Insurance
    -
    James Barr Chief Executive International Visitors
    -
    Nick Freeman Group Chief Financial Officer
    -
    Brendan Mills Group Chief Information Officer
    -
    Lauren Daniels Group Chief People Officer
    -
    Roslyn Toms Group Executive - Legal and Chief Risk OfficerCompany Secretary
    -
    Jordan French Senior Corporate CounselJoint Company Secretary
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    HSBC Custody Nominees (Australia) Limited i 84,292,191 17.38%
    Citicorp Nominees Pty Limited 47,060,124 9.70%
    J P Morgan Nominees Australia Pty Limited 46,183,080 9.52%
    National Nominees Limited 13,023,146 2.68%
    BNP Paribas Noms Pty Ltd 8,582,620 1.77%
    Citicorp Nominees Pty Limited <Colonial First State Inv A/C> 7,666,495 1.58%
    Bnp Paribas Nominees Pty Ltd <Agency Lending A/C> 5,740,371 1.18%
    Bnp Paribas Nominees Pty Ltd <Hub24 Custodial Serv Ltd> 3,682,626 0.76%
    HSBC Custody Nominees (Australia) Limited <Nt Comnwlth Super Corp A/C> 2,969,775 0.61%
    Netwealth Investments Limited <Wrap Services A/C> 1,235,303 0.25%
    Neweconomy Com Au Nominees Pty Limited <900 Account> 1,137,763 0.23%
    BNP Paribas Nominees Pty Ltd <Ib Au Noms Retailclient> 1,096,101 0.23%
    Mr Mark Anthony Fitzgibbon 1,084,491 0.22%
    Fitzy (Nsw) Pty Ltd <Fitz Family Fund A/C> 946,621 0.20%
    Cpu Share Plans Pty Ltd <Nhf Escrow Trust Master A/C> 850,693 0.18%
    HSBC Custody Nominees (Australia) Limited ii 842,297 0.17%
    Bnp Paribas Noms (Nz) Ltd 828,923 0.17%
    Netwealth Investments Limited <Super Services A/C> 826,644 0.17%
    HSBC Custody Nominees (Australia) Limited A/C 2 788,600 0.16%
    Ioof Investment Services Limited <Ips Superfund A/C> 643,141 0.13%

    Profile

    since

    Note